Tim Riley: National Drug-Shortage Crisis Starting to Impact Local Residents, Businesses

Owner of Riley Drug in Geneva, Tim Riley, speculates as to what is causing the record drug shortage this year and how it has impacted Geneva residents.

Over the past few years, prescription drug shortages have been on the rise, and in 2011 have hit an all-time high with shortages of more than 175 drugs.

Tim Riley, owner of in Geneva, says there are many causes of the shortages, which range "from manufacturing issues to shortages of raw materials.”

Many health officials have labeled this shortage a “crisis,” and FDA officials have noted that they expect it will get even worse.

The FDA defines a drug shortage as “a situation in which the total supply of all a drug, and all of its approved alternatives, is inadequate to meet demand.”

But the FDA's strict guidelines could be at least part of the problem.

“The FDA has very stringent policies regarding the manufacturing of medications, so some of the holdups in drugs are actually caused by the FDA,” Riley said. “When the FDA does its inspections, they often will discover problems or unacceptable practices and are liable to shut a line or an entire plant down.”

And when this happens, production slows and different drug companies have to take over and play catch-up while consumer demand for the drugs increases.

“If several companies are forced to shut down or have to alter their production practices, then there is a great burden left on the few remaining companies in operation,” Riley said.

It is unfeasible for fewer companies to meet consumer needs, and combined with little to no access to the raw materials to manufacture the drugs, shortages in drugs is an inevitable problem that is challenging to reverse.

“My understanding is that even if a drug company so much as changes a small brush in their operating line, even that brush has to meet certain requirements,” Riley said. “The FDA’s rules are in place to keep drugs safe, but certain protocols make it very difficult for companies to stay in business, let alone remain competitive in the market.”

Recently, over-the-counter drugs such as Tylenol and Motrin have been recalled in large quantities, making them difficult to find.

“The primary reason for this recall and the shortage of the medications is that when the FDA inspected the plant producing these drugs, they found that it was not clean, and proceeded to shut the plant down,” Riley said. "So, if you are trying to find Tylenol or Motrin, FDA’s closing of the plant is the primary reason why it is so challenging. The FDA may be partially responsible for this particular shortage, but the FDA is only trying to do its job by ensuring certain standards are met in efforts meet consumers' demands for safe, quality medications."

Over-the-counter drugs are not the only ones at risk of shortage, though. There has been a steady decline in the availability of prescription drugs over the past six years, as well.

“Right now, there are several medications that are out of market,” Riley said. “For example, Adderall, a medication for ADHD, quickly became unavailable as the generic one took over. Patients generally have to pay more for brand-name medications because when generics come out, there is more competition on the market, forcing brand name drugs to increase in price due to loss of revenue.”

This pricing gap, however, has nothing to do with the interference of insurance companies. “Some people are insistent on having a brand name drug, and if that’s the case, there’s no way around paying the higher price,” Riley said.

Some chemotherapy drugs, vitamin B-12 injections, Toprol and Maxide have experienced shortages within the last year, as well.

“Even though drug shortages have inconvenienced patients, there is no serious health hazard at this point,” Riley said.

Ryan Gallagher August 26, 2011 at 07:19 PM
Some of the above is true. But the real root of the issue is money. Outsourcing - drug companies seeking to lower costs, purchase raw materials from places like China and India. Just as our homes are filled with cheap goods from China and India, so are our medicine cabinets. When poor quality control and lax standards interfere with the flow of cheap materials (shutdowns), drug companies stop production rather than cut into profits by sourcing higher quality ingredients. Mega-corps - consolidation of drug corporations means fewer companies to produce less profitable drugs. Older, non-patentable, and generic drugs aren't big money makers. Many of the "shortages" are purely business decisions motivate by profit seeking. Big drug companies seek greater profit from newer patented medications costing dollars a pill, over generics costing pennies. Government "bargaining" - when government involves itself in price control (as with medicare/medicaid) the profit driven drug companies respond by ceasing production. If a medication becomes less profitable due to price constraints, it is no longer made. Manipulation - when life-saving medications "disappear" people die. Those desperate to get medications they need to live, will pay more. When cancer drug prochlorperazine disappeared, patients were desperate. It returned, but at double the price. Think it's bad now? Wait till nationalized medicine further undercuts the one thing motivating the drug mega-corps: profit.
TDY August 27, 2011 at 04:28 PM
Those same Drug companies set up shop in Ireland and Switzerland for tax incentives. If the U.S. gave a lowered tax for this companies it could thus bring jobs back home and generate BILLIONS in revenue.


More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »